Regulon

Regulon: R-145

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
102.57178110Pr-133Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
3574 ENSG00000104432 IL7 P13232
10553 ENSG00000109854 HTATIP2 Q9BUP3
3676 ENSG00000115232 ITGA4 P13612
1796 ENSG00000115325 DOK1 Q99704
8930 ENSG00000129071 MBD4 O95243
5778 ENSG00000143851 PTPN7 F8WF66
10491 ENSG00000170275 CRTAP O75718
4615 ENSG00000172936 MYD88 Q99836
27235 ENSG00000173085 COQ2 A0A1D8H0A6
961 ENSG00000196776 CD47 Q08722

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
ABRILUMABITGA4AntibodyINHIBITORIntegrin alpha-4/beta-7 inhibitor20
MAGROLIMABCD47AntibodyINHIBITORLeukocyte surface antigen CD47 inhibitor30
NATALIZUMABITGA4AntibodyINHIBITORIntegrin alpha-4/beta-1 inhibitor40
FIRATEGRASTITGB1Small moleculeANTAGONISTIntegrin alpha-4/beta-1 antagonist20
VEDOLIZUMABITGA4AntibodyINHIBITORIntegrin alpha-4/beta-7 inhibitor40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-145

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00691HMCN1up-regulatesPRDM1activatesR-1452116Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ABRILUMAB, MAGROLIMAB, NATALIZUMAB, FIRATEGRAST, VEDOLIZUMAB

CMF-03099LAMA3down-regulatesPRDM1activatesR-145214Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ABRILUMAB, MAGROLIMAB, NATALIZUMAB, FIRATEGRAST, VEDOLIZUMAB

CMF-04578LAMC3down-regulatesPRDM1activatesR-145217Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ABRILUMAB, MAGROLIMAB, NATALIZUMAB, FIRATEGRAST, VEDOLIZUMAB

CMF-05179XIRP2down-regulatesPRDM1activatesR-145213Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ABRILUMAB, MAGROLIMAB, NATALIZUMAB, FIRATEGRAST, VEDOLIZUMAB

CMF-09221TANC2up-regulatesPRDM1activatesR-145218Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ABRILUMAB, MAGROLIMAB, NATALIZUMAB, FIRATEGRAST, VEDOLIZUMAB

CMF-18027PRPF40Bdown-regulatesPRDM1activatesR-1452112Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ABRILUMAB, MAGROLIMAB, NATALIZUMAB, FIRATEGRAST, VEDOLIZUMAB

CMF-19502NF1up-regulatesPRDM1activatesR-1452116Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ABRILUMAB, MAGROLIMAB, NATALIZUMAB, FIRATEGRAST, VEDOLIZUMAB

CMF-19802CDH9down-regulatesPRDM1activatesR-145213Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ABRILUMAB, MAGROLIMAB, NATALIZUMAB, FIRATEGRAST, VEDOLIZUMAB

CMF-22774IDH1down-regulatesPRDM1activatesR-1452118Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ABRILUMAB, MAGROLIMAB, NATALIZUMAB, FIRATEGRAST, VEDOLIZUMAB

CMF-26276CEP250down-regulatesPRDM1activatesR-145217Drugs (5)

Regulator Drugs (0)

Regulon Drugs (5)

ABRILUMAB, MAGROLIMAB, NATALIZUMAB, FIRATEGRAST, VEDOLIZUMAB